靶向区域优化在行动:持续肝出血时部分主动脉阻断导致剂量依赖性终末器官缺血损伤
本研究在麻醉猪肝撕裂致持续出血模型中,将动物随机分为靶向区域优化(TRO)远端流量300 mL/min(n=8)、500 mL/min(n=8)、700 mL/min(n=8)三组,TRO 90分钟后行损伤控制填塞并监测6小时。TRO期间各队列平均流量偏离目标值均低于15.9%;TRO阶段各组平均肾流量差异显著(P<0.0001;TRO300=63.1±1.2;TRO500=133.70±1.93;TRO700=109.3±2.0),TRO700肾流量低于TRO500;ICU阶段TRO500与TRO700平均肾流量发生倒转(P<0.0001;TRO300=86.20±0.40;TRO500=148.50±1.45;TRO700=181.1±0.70)。实验结束时TRO300组血尿素氮、肌酐和钾更高,但各组乳酸和pH无差异。结论认为TRO技术可行,但部分主动脉阻断即开始出现剂量依赖性终末器官缺血损伤,并在重症监护阶段进展,对肾功能影响更突出。
要点
- 猪肝撕裂出血模型中TRO可按体积精确设定远端流量,各队列平均偏离目标流量均低于15.9%。
- TRO阶段平均肾流量三组差异显著(P<0.0001):TRO300=63.1±1.2、TRO500=133.70±1.93、TRO700=109.3±2.0,TRO700肾流量低于TRO500。
- ICU阶段TRO500与TRO700平均肾流量倒转(P<0.0001):TRO300=86.20±0.40、TRO500=148.50±1.45、TRO700=181.1±0.70。
- 实验结束时TRO300组血尿素氮、肌酐和钾更高,但各组乳酸和pH无差异。
- 部分主动脉阻断即开始出现剂量依赖性终末器官缺血损伤,并在重症监护阶段进展,肾脏受累更明显。
适用人群与场景
- 麻醉猪肝撕裂致持续出血模型,随机分为TRO远端流量300 mL/min(n=8)、500 mL/min(n=8)、700 mL/min(n=8)三组。
- TRO 90分钟后接受损伤控制填塞,并监测6小时。
处置流程与药物剂量
- TRO远端流量按体积设定为300 mL/min、500 mL/min或700 mL/min,TRO持续90分钟。
- TRO 90分钟后行损伤控制填塞,随后监测6小时(重症监护阶段)。
研究设计与关键结果
- 研究类型:猪在体实验;样本量:每组n=8,共24头。
- TRO期间各队列平均流量偏离目标值均低于15.9%。
- TRO阶段平均肾流量三组差异显著(P<0.0001;TRO300=63.1±1.2;TRO500=133.70±1.93;TRO700=109.3±2.0),TRO700队列肾流量低于TRO500。
- ICU阶段TRO500与TRO700平均肾流量倒转(P<0.0001;TRO300=86.20±0.40;TRO500=148.50±1.45;TRO700=181.1±0.70)。
- 实验结束时TRO300组血尿素氮、肌酐和钾更高,但各组乳酸或pH无差异。
证据类型、等级与局限
- 证据类型:动物实验(猪肝撕裂出血模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为本研究证明TRO作为长时间主动脉阻断和复苏后改善结局的策略具有技术可行性;部分主动脉阻断即开始出现剂量依赖性终末器官缺血损伤,并在重症监护阶段进展,对肾功能影响更突出。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Targeted regional optimization (TRO) describes partial resuscitative endovascular balloon occlusion of the aorta strategy that allows for controlled distal perfusion to balance hemostasis and tissue perfusion. This study characterized hemodynamics at specific targeted distal flow rates in a swine model of uncontrolled hemorrhage to determine if precise TRO by volume was possible.
METHODS: Anesthetized swine were subjected to liver laceration and randomized into TRO at distal flows of 300 mL/min (n = 8), 500 mL/min (n = 8), or 700 mL/min (n = 8). After 90 min, the animals received damage control packing and were monitored for 6 h. Hemodynamic parameters were measured continuously, and hematology and serologic labs obtained at predetermined intervals.
RESULTS: During TRO, the average percent deviation from the targeted flow was lower than 15.9% for all cohorts. Average renal flow rates were significantly different across all cohorts during TRO phase (P < 0.0001; TRO300 = 63.1 ± 1.2; TRO500 = 133.70 ± 1.93; TRO700 = 109.3 ± 2.0), with the TRO700 cohort having less renal flow than TRO500. The TRO500 and TRO700 average renal flow rates inverted during the intensive care unit phase (P < 0.0001; TRO300 = 86.20 ± 0.40; TRO500 = 148.50 ± 1.45; TRO700 = 181.1 ± 0.70). There was higher blood urea nitrogen, creatinine, and potassium in the TRO300 cohort at the end of the experiment, but no difference in lactate or pH between cohorts.
CONCLUSION: This study demonstrated technical feasibility of TRO as a strategy to improve outcomes after prolonged periods of aortic occlusion and resuscitation in the setting of ongoing solid organ hemorrhage. A dose-dependent ischemic end-organ injury occurs beginning with partial aortic occlusion that progresses through the critical care phase, with exaggerated effect on renal function.
参考来源
- Ronaldi AE, Lauria AL, Paterson JE, et al. Targeted Regional Optimization in Action: Dose-dependent End-organ Ischemic Injury with Partial Aortic Occlusion in the Setting of Ongoing Liver Hemorrhage. Shock. 2022. PMID: 35234207. doi:10.1097/SHK.0000000000001922
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。